Med Chem Res (2013) 22:2879–2888
2887
CH2piperidine), 1.57 (m, 6H, CH2piperidine), 3.93 (s, 2H, S–
CH2), 7.00–7.02 (d, J = 8.30 Hz, 2H, CHarom), 7.04–7.06
(d, J = 8.30 Hz, 2H, CHarom), 7.49–7.58 (m, 2H, CHarom),
7.82–7.84 (d, J = 7.32 Hz, 1H, CHarom), 7.97–7.99 (d,
J = 7.81 Hz, 1H, CHarom); 13C-NMR (125 MHz, CDCl3):
d 25.75, 23.08 (CH2piperidine), 53.40 (CH2piperidine), 37.31
(S–CH2), 135.81, 132.62, 131.97, 131.66, 131.54, 131.09,
129.24, 127.29, 125,52, 125.11, 119.85 (Carom), 155.77
(=C–S), 181.04, 180.59 (C=O); MS (?ESI): 420
(M ? Na)?; Anal. Calcd. for C22H20ClNO2S (M, 397.92):
C, 66.40; H, 5.07; N, 3.52; S, 8.06 %. Found C, 66.07; H,
4.97, N, 3.56; S, 7.56 %.
2-((4-Chlorobenzyl)thio)-3-thiomorpholinonaphthalene-
1,4-dione (12e) was synthesized by the reaction of 10
(0.45 g, 1.29 mmol) and 11e (0.27 g, 2.58 mmol) by gen-
eral procedure 3.
(12e):Purple oil; yield 0.49 g (91 %); Rf: 0.83 (CHCl3);IR
(KBr): t (cm-1) 3063 (C–Harom), 2958, 2909, 2840
(C–Haliph), 1592, 1537 (C=C), 1667, 1642 (C=O); 1H-NMR
(500 MHz, CDCl3): d 2.66 (t, J = 4.88 Hz, 4H, CH2thi-
omorpholine), 3.47 (t, J = 4.88 Hz, 4H, CH2thiomorpholine), 4.03
(s, 2H, S–CH2), 7.03–7.05 (d, J = 8.29 Hz, 2H, CHarom),
7.08–7.11 (d, J = 8.30 Hz, 2H, CHarom), 7.56–7.64 (m, 2H,
CHarom), 7.88–7.89 (d, J = 7.32 Hz, 1H, CHarom), 8.00–8.02
(d, J = 6.83 Hz, 1H, CHarom);13C-NMR (125 MHz, CDCl3):
d 55.27 (CH2thiomorpholine), 28.27 (CH2thiomorpholine), 38.51
(S–CH2), 136.80, 134.04, 133.28, 133.19, 133.01, 132.21,
130.48, 128.73, 126.92, 126.57, 125.69 (Carom), 156.65
(=C–S), 182.21, 181.88 (C=O); MS (?ESI): 438 (M ? Na)?,
379 (M-Cl)?; Anal. Calcd. for C21H18ClNO2S2 (M, 415.96):
C, 60.64; H, 4.36; N, 3.37; S, 15.42. Found C, 60.33; H, 4.25,
N, 3.30; S, 14.95 %.
2-(4-Chlorobenzylthio)-3-(pyrrolidin-1-yl)naphthalene-
1,4-dione (12c) was synthesized by the reaction of 10
(0.4 g, 1.15 mmol) and 11c (0.163 g, 2.30 mmol) by gen-
eral procedure 3.
(12c): Brown oil; yield 0.42 g (95 %); Rf: 0.38 (CHCl3);
IR (KBr): t (cm-1) 3064 (C–Harom), 2973, 2875 (C–Haliph),
1592, 1506 (C=C), 1674, 1621 (C=O); 1H-NMR
(500 MHz, CDCl3): d 1.74 (m, 4H, CH2pyrrolidine), 3.62 (m,
4H, CH2pyrrolidine), 3.73 (s, 2H, S–CH2), 7.00–7.02 (d,
J = 8.79 Hz, 2H, CHarom), 7.09–7.10 (d, J = 8.30 Hz, 2H,
CHarom), 7.48–7.61 (m, 2H, CHarom), 7.76–7.78 (d,
J = 7.80 Hz, 1H, CHarom), 8.00–8.02 (d,3J = 6.35 Hz, 1H,
CHarom); 13C-NMR (125 MHz, CDCl3): d 24.42 (CH2pir-
olidin), 53.37 (CH2pyrrolidine), 38.36 (S–CH2), 135.87,
132.96, 132.64, 131.66, 130.77, 130.72, 129.26, 127,28,
125.06, 124.73, 105.38 (Carom), 155.73 (=C–S), 183.18,
179.61 (C=O); MS (?ESI): 406 (M ? Na)?, 348 (M-Cl)?;
Anal. Calcd. for C21H18ClNO2S (M, 383.89): C, 65.70; H,
4.73; N, 3.65; S, 8.34 %. Found C, 65.50; H, 4.60, N, 3.53;
S, 7.35 %.
2-((4-Chlorobenzyl)thio)-3-(4-(hydroxydiphenylmeth-
yl)piperidin-1-yl)naphthalene-1,4-dione (12f) was syn-
thesized by the reaction of 10 (0.50 g, 1.44 mmol) and
11f (0.768 g, 2.88 mmol) by general procedure 3.
(12f): Purple solid; yield 0.75 g (90 %); m.p.
101–102 °C; Rf : 0.15 (CHCl3); IR (KBr): t (cm-1) 3064
(C–Harom), 2935, 2853 (C–Haliph), 1593, 1533 (C=C), 1669,
1634 (C=O); 1H-NMR (500 MHz, CD3OD): d 1.53 (m, 2H,
CH2piperidine), 1.69 (t, J = 7.32 Hz, 2H, CH2piperidine), 2.78
(m, 1H, CHpiperidine), 3.25 (m, 2H, CH2piperidine), 3.64 (t,
J = 7.32 Hz, 2H, CH2piperidine), 3.93 (s, 2H, S–CH2), 5.48
(s, 1H, OH), 7.07–7.11 (m, 4H, CHarom), 7.15–7.18 (m, 2H,
CHarom), 7.27–7.31 (m, 4H, CHarom), 7.53–7.55 (m, 4H,
CHarom), 7.68–7.72 (m, 2H, CHarom), 7.88–7.87 (d,
J = 7.32 Hz, 1H, CHarom), 7.97–7.99 (d, J = 7.32 Hz, 1H,
CHarom); 13C-NMR (125 MHz, CD3OD): d 53.82, 43.83,
27.64 (CH2piperidine), 37.79 (S–CH2), 79.38 ((Ph)2–C–OH),
146.56, 137.16, 133.75, 132.97, 132.75, 132.51, 132.28,
130.51, 128.07, 127.80, 126,37, 126.14, 125.73, 119.20
(Carom), 157.53 (=C–S), 182.05, 182.01 (C=O); MS
(?ESI): 602 (M ? Na)?, 544 (M-Cl)?; Anal. Calcd. for
C35H30ClNO3S (M, 580.14): C, 72.46; H, 5.21; N, 2.41; S,
5.53 %. Found C, C, 72.10; H, 5.20, N, 2.01; S, 4.65 %.
2-(4-Chlorobenzylthio)-3-(4-(2-fluorophenyl)piperazin-
1-yl)naphthalene-1,4-dione (12d) was synthesized by the
reaction of 10 (0.4 g, 1.15 mmol) and 11d (0.42 g,
2.30 mmol) by general procedure 3.
(12d): Brown oil; yield 0.50 g (88 %); Rf: 0.59
(CHCl3); IR (KBr): t (cm-1) 3066, 3015 (C–Harom), 2903,
2839 (C–Haliph), 1592, 1532 (C=C), 1669, 1638 (C=O);
1H-NMR (500 MHz, CDCl3): d 3.09 (t, J = 4.88 Hz, 4H,
CH2piperazin), 3.50 (t, J = 6.35 Hz, 4H, CH2piperazine), 3.99
(s, 2H, S–CH2), 6.86–7.02 (m, 5H, CHarom), 7.02–7.04 (d,
J = 8.30 Hz, 2H, CHarom), 7.06–7.08 (d, J = 8.80 Hz, 2H,
CHarom), 7.54–7.62 (m, 2H, CHarom), 7.87–7.89 (d,
J = 7.80 Hz, 1H, CHarom), 8.00–8.02 (d, J = 7.80 Hz, 1H,
CHarom); 13C-NMR (125 MHz, CDCl3): d 53.05, 51.46
(CH2piperazine), 38.66 (S–CH2), 156.99, 155.03, 136.90,
134.07, 133.11, 132.24, 130.53, 128.70, 126.90, 126.54,
124.79, 124.77, 123.19, 122.90, 119.46, 119.44, 116.39
(Carom), 156.01 (=C–S), 182.07, 181.98 (C=O); MS
(?ESI): 515 (M ? Na)?; Anal. Calcd. for C27H22
ClFN2O2S (M, 492.99): C, 65.78; H, 4.50; N, 5.68; S,
6.50 %. Found C, 65.48; H, 4.25, N, 5.38; S, 5.96 %.
Antifungal and antibacterial evaluation
Diffusion technique
Antibacterial activity of compounds was evaluated by
diffusion in peptone on nutrient medium (meat-extract agar
for bacteria; wort agar for fungi). The microbial loading
was 109 cells (spores)/1 mL. The required incubation
periods were as: 24 h at 35 °C for bacteria and 48–72 h at
123